Carisma Therapeutics, Inc. (CARM) Financials

CARM Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2025 6.6 million 7.4 million
June 30, 2025 5.0 million 51.0 million
March 31, 2025 16.0 million 52.6 million
Dec. 31, 2024 30.5 million 58.4 million

CARM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2025 1.9 million 421000
June 30, 2025 -5.9 million 431000
March 31, 2025 -10.1 million 508000
Dec. 31, 2024 -8.4 million 852000

CARM Net Income

No data available :(

CARM Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2025 2.8 million - 762000
June 30, 2025 2.0 million - 1.7 million
March 31, 2025 7.7 million - 2.3 million
Dec. 31, 2024 18.8 million - 2.5 million

CARM Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2025 41.9 million
June 30, 2025 41.8 million
March 31, 2025 41.8 million
Dec. 31, 2024 41.5 million

CARM Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2025 - 197000 1.2 million -
June 30, 2025 - 2.4 million 3.4 million -
March 31, 2025 - 9.2 million 3.9 million -
Dec. 31, 2024 - 15.6 million 7.9 million 1.9 million

CARM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2025 45.3 million -
June 30, 2025 - 356000
March 31, 2025 3.7 million 1.5 million
Dec. 31, 2024 3.7 million 669000

CARM Revenue by Segment
Graph available only for paid members. Upgrade to see it.

CARM

Price: $0.02

52 week price:
0.00
1.27

Earnings Per Share: 0.19 USD

P/E Ratio: 0.00

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 4185

Links: